{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:48:28Z","timestamp":1788551308550,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693135"],"award-info":[{"award-number":["2021M693135"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H080002"],"award-info":[{"award-number":["LY20H080002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY20H080004"],"award-info":[{"award-number":["LY20H080004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971991"],"award-info":[{"award-number":["81971991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.actbio.2022.04.005","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T21:27:22Z","timestamp":1649453242000},"page":"246-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane"],"prefix":"10.1016","volume":"145","author":[{"given":"Bin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changcan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenmeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2022.04.005_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2022.04.005_bib0002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.envres.2016.03.036","article-title":"Traffic-related air pollution and childhood acute leukemia in Oklahoma","volume":"148","author":"Janitz","year":"2016","journal-title":"Environ. Res."},{"key":"10.1016\/j.actbio.2022.04.005_bib0003","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00277-010-1118-7","article-title":"Leukemia stem cells","volume":"90","author":"Testa","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.actbio.2022.04.005_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ccell.2016.06.011","article-title":"Context, context, context: new gene programs linked to bad behavior in MLL-AF9-initiated leukemia","volume":"30","author":"Watanabe","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.actbio.2022.04.005_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3324\/haematol.11575","article-title":"Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model","volume":"93","author":"Montesinos","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.actbio.2022.04.005_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","article-title":"Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation","volume":"47","author":"Cleary","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2022.04.005_bib0007","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.actbio.2022.04.005_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2022.04.005_bib0009","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2022.04.005_bib0010","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2022.04.005_bib0011","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bjh.12457","article-title":"ABT-199 selectively inhibits BCL2 but not BCL2L1 and efficiently induces apoptosis of chronic lymphocytic leukaemic cells but not platelets","volume":"163","author":"Vogler","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.actbio.2022.04.005_bib0012","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and Venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2022.04.005_bib0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2022.04.005_bib0014","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1182\/blood.2020007651","article-title":"Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia","volume":"137","author":"Niu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2022.04.005_bib0015","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","article-title":"Binding of released Bim to Mcl-1 is a mechanism of intrinsic resistance to ABT-199 which can be overcome by combination with daunorubicin or cytarabine in AML cells","volume":"22","author":"Niu","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.04.005_bib0016","first-page":"e302","article-title":"Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors","volume":"100","author":"Thijssen","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.actbio.2022.04.005_bib0017","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1158\/1078-0432.CCR-19-0361","article-title":"Tumor lysis, adverse events, and dose adjustments in 297 Venetoclax-treated CLL patients in routine clinical practice","volume":"25","author":"Roeker","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.04.005_bib0018","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1182\/hematology.2020000120","article-title":"Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia","volume":"2020","author":"Fischer","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.actbio.2022.04.005_bib0019","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2147\/IJN.S190027","article-title":"Idarubicin-loaded methoxy poly(ethylene glycol)-b-poly(l-lactide-co-glycolide) nanoparticles for enhancing cellular uptake and promoting antileukemia activity","volume":"14","author":"Liang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2022.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.biomaterials.2005.09.017","article-title":"The in vivo and in vitro degradation behavior of poly(trimethylene carbonate)","volume":"27","author":"Zhang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.04.005_bib0021","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1016\/j.biomaterials.2005.03.036","article-title":"Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers","volume":"26","author":"Mao","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.04.005_bib0022","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2021.04.009","article-title":"PEG-based thermosensitive and biodegradable hydrogels","volume":"128","author":"Shi","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.04.005_bib0023","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1039\/C6TB01841F","article-title":"PCL-PEG graft copolymers with tunable amphiphilicity as efficient drug delivery systems","volume":"4","author":"Al Samad","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2022.04.005_bib0024","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.actbio.2009.02.005","article-title":"Constructing doxorubicin-loaded polymeric micelles through amphiphilic graft polyphosphazenes containing ethyl tryptophan and PEG segments","volume":"5","author":"Qiu","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.04.005_bib0025","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1039\/D1TB00759A","article-title":"Poly(trimethylene carbonate) flexible intestinal anastomosis scaffolds to reduce the probability of intestinal fistula and obstruction","volume":"9","author":"Ren","year":"2021","journal-title":"J. Mater. Chem.. B"},{"key":"10.1016\/j.actbio.2022.04.005_bib0026","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2004-10-4011","article-title":"Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms","volume":"105","author":"Song","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2022.04.005_bib0027","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12967-020-02384-y","article-title":"WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target","volume":"18","author":"Zhou","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.actbio.2022.04.005_bib0028","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2022.04.005_bib0029","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood-2015-04-639062","article-title":"Overexpression and knockout of miR-126 both promote leukemogenesis","volume":"126","author":"Li","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2022.04.005_bib0030","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1158\/1078-0432.CCR-15-0364","article-title":"BCL-2 antagonism to target the intrinsic mitochondrial pathway of apoptosis","volume":"21","author":"Gibson","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2022.04.005_bib0031","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/s41591-018-0233-1","article-title":"Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia","volume":"24","author":"Pollyea","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2022.04.005_bib0032","doi-asserted-by":"crossref","first-page":"e98270","DOI":"10.1371\/journal.pone.0098270","article-title":"DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2022.04.005_bib0033","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2022.04.005_bib0034","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.actbio.2022.04.005_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2011.03.025","article-title":"Traveling Bax and forth from mitochondria to control apoptosis","volume":"145","author":"Soriano","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2022.04.005_bib0036","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ceb.2003.10.004","article-title":"Bcl-2-family proteins and the role of mitochondria in apoptosis","volume":"15","author":"Kuwana","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.actbio.2022.04.005_bib0037","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.7150\/thno.40395","article-title":"ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury","volume":"10","author":"Yu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2022.04.005_bib0038","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","article-title":"Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer's disease","volume":"10","author":"Kwon","year":"2016","journal-title":"ACS nano"},{"key":"10.1016\/j.actbio.2022.04.005_bib0039","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.actbio.2021.04.054","article-title":"Mitochondria-targeted graphene for advanced cancer therapeutics","volume":"129","author":"Tabish","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.04.005_bib0040","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/bloodadvances.2019000360","article-title":"Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment","volume":"3","author":"de Weerdt","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.actbio.2022.04.005_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics8010005","article-title":"Venetoclax (ABT-199) might act as a perpetrator in pharmacokinetic drug-drug interactions","volume":"8","author":"Weiss","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.actbio.2022.04.005_bib0042","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ijlh.13241","article-title":"Junior, P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications","volume":"42","author":"da Silveira Junior","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.actbio.2022.04.005_bib0043","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","article-title":"Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation","volume":"133","author":"Danhier","year":"2009","journal-title":"J. Controll. Rel."},{"key":"10.1016\/j.actbio.2022.04.005_bib0044","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/j.actbio.2012.12.030","article-title":"Multifunctional triblock co-polymer mP3\/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing","volume":"9","author":"Zhou","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2022.04.005_bib0045","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2006-02-004234","article-title":"Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53","volume":"109","author":"Irish","year":"2007","journal-title":"Blood"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122002021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122002021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:50:56Z","timestamp":1761673856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122002021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":45,"alternative-id":["S1742706122002021"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.04.005","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}